A Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Pain from Osteoarthritis of the Knee

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Pain from Osteoarthritis of the Knee

Discontinued
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2013

At a glance

  • Drugs ABT 110 (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
  • Sponsors Abbott GmbH & Co. KG
  • Most Recent Events

    • 26 Jan 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 22 Sep 2012 Planned End Date changed from 29 Jul 2013 to 2 Dec 2013 as reported by European Clinical Trials Database record.
    • 14 Jul 2012 Actual initiation date changed from 29 Mar 2012 to 2 Jul 2012, as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top